Dentsply Sirona (XRAY) Misses Q1 EPS by 1c, provides guidance
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
Price: $11.38 -0.44%
EPS Growth %: -36.0%
Financial Fact:
Gross profit: 513.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -36.0%
Financial Fact:
Gross profit: 513.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Dentsply Sirona (NASDAQ: XRAY) reported Q1 EPS of $0.27, $0.01 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $880 million versus the consensus estimate of $842.58 million.
GUIDANCE:
Dentsply Sirona sees FY2026 EPS of $1.40-$1.50, versus the consensus of $1.43. Dentsply Sirona sees FY2026 revenue of $3.5-3.6 billion, versus the consensus of $3.576 billion.
For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Shake Shack (SHAK) at Outperform
- Seaport Global Securities Upgrades Asbury Automotive Group (ABG) to Buy
- Barclays Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
